| Participating in KIMES 2025, Showcasing Cloud-Based Clinical Innovation Strategies for Medical Devices
| Offering Tailored Consulting for Pre-Registered Companies, Supporting Global Market Entry and Regulatory Approvals
| AWS Certified MSP: Enhancing Clinical and Medical Data Management with AWS Cloud
| Strengthening Clinical and Global Regulatory Consulting, Boosting Global Competitiveness through Data Management Innovation
JNPMEDI, a clinical trial consulting and platform company, announced on the 18th that it will participate in the 40th Korea International Medical & Hospital Equipment Show (KIMES 2025), which will be held at COEX in Samseong-dong, Seoul, from the 20th to the 23rd. The company will operate a booth to showcase its clinical operations for medical devices and cloud-based innovative clinical and medical data management strategies for domestic and international pharmaceutical and biotech companies.
JNPMEDI plans to offer tailored consulting services for pre-registered companies, providing solutions to help expedite and streamline clinical trials and global regulatory approval processes. The company will also introduce a variety of services to support market entry for these companies both domestically and internationally. Through this, businesses will be able to experience first-hand the continuous optimization strategies reflecting the latest technologies, ensuring stable operations.
Additionally, JNPMEDI will present a cloud-based clinical and medical data management solution powered by AWS (Amazon Web Services). This solution will help companies reduce initial infrastructure costs and operate their research and clinical trials more systematically. Furthermore, it will accelerate the digital transformation of pharmaceutical and biotech companies, assisting in strengthening their competitiveness in the global market through innovation in clinical and medical data management.
Recently, JNPMEDI was selected as an AWS Certified Managed Service Provider (MSP). As a result, at KIMES 2025, the company will showcase innovative digital transformation solutions, ensuring compliance with security standards to protect sensitive data, optimizing costs through cloud resource management, and adjusting infrastructure to match the scale and needs of research.
CEO KwunHo Jeong of JNPMEDI stated, "Through KIMES 2025, we aim to raise awareness of JNPMEDI’s capabilities in clinical trial and global regulatory consulting and set a new standard for clinical and medical data management with AWS-based cloud solutions. Moving forward, we plan to expand our network with domestic and international medical device companies and strengthen our position in the global market."
Meanwhile, JNPMEDI plans to further advance its global regulatory and clinical consulting services for pharmaceutical and biotech companies through its participation in KIMES 2025. Additionally, the company will develop various solutions for global market entry utilizing AWS technologies and engage in continuous collaboration discussions.
| Participating in KIMES 2025, Showcasing Cloud-Based Clinical Innovation Strategies for Medical Devices
| Offering Tailored Consulting for Pre-Registered Companies, Supporting Global Market Entry and Regulatory Approvals
| AWS Certified MSP: Enhancing Clinical and Medical Data Management with AWS Cloud
| Strengthening Clinical and Global Regulatory Consulting, Boosting Global Competitiveness through Data Management Innovation
JNPMEDI, a clinical trial consulting and platform company, announced on the 18th that it will participate in the 40th Korea International Medical & Hospital Equipment Show (KIMES 2025), which will be held at COEX in Samseong-dong, Seoul, from the 20th to the 23rd. The company will operate a booth to showcase its clinical operations for medical devices and cloud-based innovative clinical and medical data management strategies for domestic and international pharmaceutical and biotech companies.
JNPMEDI plans to offer tailored consulting services for pre-registered companies, providing solutions to help expedite and streamline clinical trials and global regulatory approval processes. The company will also introduce a variety of services to support market entry for these companies both domestically and internationally. Through this, businesses will be able to experience first-hand the continuous optimization strategies reflecting the latest technologies, ensuring stable operations.
Additionally, JNPMEDI will present a cloud-based clinical and medical data management solution powered by AWS (Amazon Web Services). This solution will help companies reduce initial infrastructure costs and operate their research and clinical trials more systematically. Furthermore, it will accelerate the digital transformation of pharmaceutical and biotech companies, assisting in strengthening their competitiveness in the global market through innovation in clinical and medical data management.
Recently, JNPMEDI was selected as an AWS Certified Managed Service Provider (MSP). As a result, at KIMES 2025, the company will showcase innovative digital transformation solutions, ensuring compliance with security standards to protect sensitive data, optimizing costs through cloud resource management, and adjusting infrastructure to match the scale and needs of research.
CEO KwunHo Jeong of JNPMEDI stated, "Through KIMES 2025, we aim to raise awareness of JNPMEDI’s capabilities in clinical trial and global regulatory consulting and set a new standard for clinical and medical data management with AWS-based cloud solutions. Moving forward, we plan to expand our network with domestic and international medical device companies and strengthen our position in the global market."
Meanwhile, JNPMEDI plans to further advance its global regulatory and clinical consulting services for pharmaceutical and biotech companies through its participation in KIMES 2025. Additionally, the company will develop various solutions for global market entry utilizing AWS technologies and engage in continuous collaboration discussions.